Weak yes - which is why we need the study. However, the data we DO have shows a 92% efficacy among people without a second dose. I don't see how this is so weak we should not seriously consider it. 2/983 vs 28/1059. Durability unknown - some ppl go out to 108 days.
-
-
But as discussed, not if the sci/empirical evid. jury is still out. Good idea or not a different issue from concern/goal to address misinfo abt it and its potential impacts. Comes down to framing for a lay audience & using tactics like eg truth sandwich... 1/
-
...facts/what we know, then misinfo, then facts/what we know again. For potentially misunderstood findings (eg mask study), publish along w/ invited comments with eye for misunderstanding, working w/sci journalists. 2/2
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.